Achieving durable response with PD-1 inhibitor therapy in relapsed metastatic squamous cell lung cancer
24 Feb 2026
byDr. Stephen L. Chan, Associate Professor, Department of Clinical Oncology, Chinese University of Hong Kong
A 71-year-old male former smoker, who quit smoking in 2014, presented with cough in February 2015. CT and PET-CT scans in March 2015 showed T4N0M0 disease (stage IIIA), with an 8 cm hypermetabolic soft tissue mass at the right upper lobe (RUL) of the lung. Mild activity was also noted in the right hilar lymph node region.